SCHEMBL8239476

SCHEMBL8239476

Cc1cc2c(cc1C)OC(F)(F)O2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
GPR3 P46089 1/20 0.38
STIM1 Q13586 2/20 0.37
ORAI1 Q96D31 2/20 0.37
CTNNB1 P35222 2/20 0.34
WNT3A P56704 2/20 0.34
NOTUM Q6P988 1/20 0.33
SCN9A Q15858 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CG P48736 1/20 0.33
KIF11 P52732 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
P2RX7 Q99572 2/20 0.32
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31
RXRA P19793 2/20 0.30
GRIN1 Q05586 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367746 0.85 STIM1 (0.40) TSHRGPR3STIM1ORAI1CTNNB1
SCHEMBL8237644 0.84 STIM1 (0.33) TSHRGPR3STIM1ORAI1CTNNB1
SCHEMBL16076086 0.84 TSHR (0.42) TSHRGPR3STIM1ORAI1PIK3CA
SCHEMBL8236665 0.84 CD44 (0.43) TSHRGPR3STIM1ORAI1P2RX7
SCHEMBL12279630 0.84 STIM1 (0.33) TSHRGPR3STIM1ORAI1CTNNB1
SCHEMBL1702518 0.84 STIM1 (0.33) TSHRGPR3STIM1ORAI1CTNNB1
SCHEMBL24793422 0.80 P2RX7 (0.37) TSHRGPR3STIM1ORAI1SCN9A
SCHEMBL12744390 0.80 P2RX7 (0.39) STIM1ORAI1P2RX7
SCHEMBL25028967 0.80 ULK1 (0.33) TSHRGPR3STIM1ORAI1NOTUM
SCHEMBL25027513 0.79 GRIA1 (0.39) TSHRGPR3STIM1ORAI1CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115641-A1 NONCOVALENT KEAP1-NRF2 SMALL-MOLECULE INHIBITORS UNIVERSITY OF COPENHAGEN (DK) 2024-06-06 WO disclosed
US-9795599-B2 CCR6 compounds CHEMOCENTRYX, INC. (US) 2017-10-24 US disclosed
US-20160296508-A1 CCR6 COMPUNDS CHEMOCENTRYX, INC. 2016-10-13 US disclosed
US-9340509-B2 CCR6 compounds CHEMOCENTRYX, INC. (US) 2016-05-17 US disclosed
US-20150175547-A1 CCR6 COMPOUNDS CHEMOCENTRYX, INC. 2015-06-25 US disclosed
WO-2015084842-A1 CCR6 COMPOUNDS CHEMOCENTRYX, INC. (US) 2015-06-11 WO disclosed
US-7910614-B2 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same BASF SE (DE) 2011-03-22 US disclosed
US-20090325801-A1 Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same BASF SE (DE) 2009-12-31 US disclosed
WO-2007089034-A1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160296508-A1 CCR6 COMPUNDS CCR6, CCR1, CCR4 TSHR 3038/4885GPR3 2324/4885STIM1 2158/4885
US-20150175547-A1 CCR6 COMPOUNDS CCR6, CCR1, CCR4 TSHR 3545/4885GPR3 1117/4885STIM1 1770/4885
US-20090325801-A1 Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same CBR3, NAT1, CBR1 TSHR 2597/4885GPR3 3739/4885STIM1 2731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.